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ABSTRACT
Objective: Identification of the symptoms of bacterial vaginosis (BV) in pregnancy might be rational
in order to identify a possible BV-associated group at risk of preterm delivery.
Methods: Three hundred and five women early in the third trimester of pregnancy were inter-
viewed about lifestyle factors and specific symptoms of BV and given a vaginal examination. A
longitudinal three-week follow-up was conducted for 127 women.
Results: The prevalence ofBV was 16%. Women with BV were significantly more often smokers
than women without BV (52% vs. 34%). No difference in sexual activity or other behavioral
characteristics between the two groups were seen. No differences were noted among women with
and without BV according to specific symptoms: malodorous discharge (26% vs. 23%), increased
discharge (76% vs. 68%), or itching or troublesome discharge. More than one third ofwomen with
BV at the first examination did not fulfill the criteria for BV at the three week follow-up exam.
None of the women without BV had developed BV by the follow-up exam. The incidence of
preterm delivery among women with BV was 4%, women without BV had an incidence of 2.4%.
This difference was not statistically significant.
Conclusion: Asymptomatic BV in pregnancy is common. Specific questions about the character
of the discharge do not identify women with BV during pregnancy. To identify a potential BV-
associated group at risk for preterm delivery, screening for BV must be conducted not only among
symptomatic women but among all women. Women with BV are more often smokers than women
without BV. Infect. Dis. Obstet. Gynecol. 5:361-365, 1997. (C) 1998 Wiley-Liss, Inc.
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acterial vaginosis (BV) has been linked to nu-
merous gynecologic and obstetric complica-
tions. Bacterial vaginosis in pregnancy has been as-
sociated with increased risk of preterm delivery
and delivery of low-birth-weight infants 1-4 and
postpartum complications, such as endometritis
and postcesarean infections,s
The most critical period in pregnancy concern-
ing vaginal infections seems to be the first and
second trimesters.6-8 The presence of an abnormal
bacterial flora in early and mid pregnancy is
thought to induce labor by stimulating the produc-
tion of bacterial cytolytic enzymes and substances
produced by bacteria-induced inflammatory cells
or result from a subclinical infection in the uterus.6
If BV is a predictor for adverse pregnancy out-
come, screening during pregnancy and subsequent
treatment might be rational. McGregor9 has recom-
mended screening all pregnant women and treating
those with BV. He showed a significant reduction
in preterm deliveries among women who were
treated for BV during pregnancy compared with
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women with BV who were not treated. However,
whether pregnant women with asymptomatic BV
should be treated remains controversial. 1, 11
Recently, it has been shown that the presence of
BV decreases spontaneously as the pregnancy pro-
ceeds. Bacterial vaginosis persists in fewer than
60% of women from the first to the third trimester
of pregnancy. Women without BV very rarely de-
velop BV during pregnancy, lz, 13
The symptoms of BV are nonspecific and in-
clude troublesome vaginal discharge, primarily a
foul-smelling discharge. 14, is How the symptoms
may change during pregnancy in relation to BV is
unknown, but in a discussion of the "screen and
treat" method, this knowledge seems crucial. In an
attempt to identify women with increased risk of
BV, we conducted a study to investigate the symp-
tomatology of BV and the longitudinal, changes of
BV during pregnancy.
SUBJECTS AND METHODS
The study was carried out in a midwife clinic in the
city of Aarhus, Denmark, and the protocol was ap-
proved by the regional ethics committee. Women
scheduled for routine prenatal visits in the 30th and
33rd week of pregnancy were invited to participate.
Women below 18 years of age and women who
had received antibiotics within two weeks prior to
the visit were excluded. Women who entered the
study during the 30th gestational week were asked
to participate in a similar examination in the 33rd
gestational week if possible.
Prior to vaginal examination, all women were
interviewed about obstetric complications during
previous pregnancies and the present pregnancy.
They were asked about the presence of specific
symptoms related to vaginal discharge, i.e., wheth-
er the discharge was increased, malodorous,
troublesome, or caused itching.
The examination included evaluation of vaginal
discharge with respect to amount, consistency, and
color, pH-measurement of discharge from the pos-
terior fornix with indicator paper, and an amine test
(mixing two drops of 10% potassium hydroxide
with discharge from the posterior fornix). A wet
smear was made at each examination by adding one
drop of physiological saline solution to discharge
from the posterior fornix. The wet smear was ex-
amined for motile trichomonas and clue cells im-
mediately using a phase contrast microscope with
TABLE I. Characteristics of women in the study
and the background population of pregnant women
who delivered at the Department of Obstetrics and
Gynecology, Aarhus University Hospital, Aarhus,
Denmark, during 1991
Study
participants Nonparticipants
Maternal n 305 n 3,818
characteristics Mean (SD) Mean (SD)
Age (years) 29. (4.6) 28.8 (4.9)
Prepregnant weight (kg) 61.4 (I 0.4) 61. (10.0)
Height (cm) 167.5 (6.0) 167.3 (6.3)
Smokers (%) 42.3 45.0
Nullipara (%) 54.8 5 I.
400x magnification in 5-10 high-power fields. Clue
cells were identified as vaginal epithelial cells with
indistinct cell borders obscured by numbers of at-
tached bacteria. 16 Bacterial vaginosis was then di-
agnosed according to the classical criteria estab-
lished by Amsel et al. 14 with presence of three of
the following four criteria: 1) thin and homoge-
neous vaginal discharge; 2) vaginal pH less than
4.5; 3) a positive amine test; and 4) the presence of
clue cells identified in the wet smear.
All women were examined for Chlamydia tracho-
matis, Neisseria gonorrhoeae, and group B strepto-
cocci using standard laboratory tests. Women found
to be positive for chlamydia were treated with oral
erythromycin (500 mg twice a day for 10 days).
All interviews and vaginal examinations were
carried out by the same person (JB).
All women in the study were also part of a large
cohort study described in detail elsewhere. 17 This
study provided information on medical and obstet-
ric data and lifestyle factors.
Categorical variables were compared by chi-
square test. A two-tailed P value less than 0.05 was
considered statistically significant.
RESULTS
The study comprised 305 women. With respect to
various background characteristics, the participants
were similar to the entire population of pregnant
women who gave birth at our department during
1991 (Table 1).
The prevalence of BV among women who en-
tered the study group (women at 30-33 weeks ges-
tation) was 16% (n 49). Women with BV were
significantly more often smokers than women with-
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TABLE 2. Characteristics of women with and
without bacterial vaginosis (BV) in early third
trimester
BV
n=49
Maternal characteristics Mean SD
Non-BV
n 256
Mean SD
Age (years) 30
Prepregnant weight (kg) 62
Height (cm) 167
Nullipara (%)a 39
Previous preterm
delivery (%)a 10
Smoker (%)b 52
Employed (%) 51
Single (%) II
Sexually active during third
trimester (%) 65
Urinary tract infection
during pregnancy (%) 15
Vaginal bleeding in early
pregnancy (%)a 10
Premature contractions (%) 12
(4.5)
(0.3)
(5.9)
29
61
168
46
8
34
53
7
(4.7)
(10.4)
(6.4)
59
5
17
aDifference was not statistically significant.
bp < 0.05.
out BV. However, women with and without BV
were comparable with respect to other characteris-
tics such as age, marital and employment status,
parity, and complications during pregnancy (in-
cluding urogenital infections, frequent and painful
contractions, and vaginal bleeding) (Table 2). More
than two thirds of all the women reported an in-
creased amount of vaginal discharge, and when
specifically asked, about one fourth had noticed a
more malodorous discharge during pregnancy
(Table 3). No discrepancy in the recordings of the
discharge (the amount, smell, or whether it caused
itching or burning sensation) was found between
women with and without BV. The women with BV
did not feel more worried about the change in char-
acter of their discharge than women without BV,
and none of the participating women had seen a
doctor because of the discharge changes.
Eight women in our study delivered preterm,
making an overall rate of preterm delivery of 2.6%
(8/30.5). The incidence of preterm delivery among
women with BV was 4.0% (2/49), and among
women without BV the incidence was 2.4% (6/25;6).
This difference was not statistically significant.
The three-week follow-up examination of 125;
of the 305 women initially examined revealed that
62% (13/21) of the women with BV at the first
examination still had BV three weeks later, while
TABLE 3. Symptoms in early third trimester among
305 pregnant women with and without bacterial
vaginosis (BV)
BV Non-BY
(n 49) (n 256)
Symptoms % %
Increased discharge 76 68
Vaginal itching and burning 16 15
Malodorous discharge 26 23
Pronounced malodorous discharge 4 5
Troublesome discharge 32 27
Differences were not statistically significant.
38% (8/21) no longer fulfilled the diagnostic criteria
for BV at the second examination. Of these eight
women without BV at the second examination, one
did not fulfill any of Amsel’s criteria for BV while
the other seven had a raised pH or a positive amine
test or both and four had a smear dominated by
very short lactobacilli. Of the 104 women initially
found to be without BV, none had developed BV
by the second visit three weeks later.
A total of 5% of the women were infected with
Chlamydia trachomatis when they entered the study
in the 30th to 33rd week of gestation. Group B
streptococci were cultured in 9%, and no women
were found to have Neisseria gonorrhoeae. Tricho-
monas vaginalis was not found in any wet smear. No
difference in the presence of any of these organ-
isms were found between women with and without
BV (Table 4).
DISCUSSION
We found a prevalence of BV of 16% among
women who attended routine antenatal care at 30
weeks gestation. This is in accordance with find-
ings from another Danish study, in which research-
ers found a prevalence of BV of 14% among 2,927
pregnant women (personal communication with
Poul Thorsen, MD). BV has been diagnosed in
12_33%9. 13 of pregnant women in other popula-
tions. However, studies on BV in pregnancy are
difficult to compare, mostly because of the hetero-
geneity among study populations, differences in
gestational age at examination, and differences in
the diagnostic criteria. Among 10,397 American
pregnant women participating in the Vaginal Infec-
tion and Prematurity Study3 the prevalence of BV
was 16% among women at 23-26 weeks of gesta-
tion.
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TABLE 4. Findings in early third trimester among
305 pregnant women with and without bacterial
vaginosis (BV)
BV Non-BV
(n 49) (n 256)
Findings % %
Chlamydia trachomatis infection 4
Group B streptococci 6
Neisseria gonorrhoeae infection 0
Trichomonas vaginalis infection 0
aDifferences were not statistically significant.
The most prominent symptom of BV is probably
malodorous discharge 1-s and not increased amount
of discharge. We presumed that by more specific
and precise questioning about the characteristics of
the vaginal discharge, we would be able to identify
women with BV. However, more than two thirds of
the women in our study reported increased amount
of discharge and nearly one fourth reported mal-
odorous discharge. No difference in the reporting
of amount or odor of the discharge was Observed
between women with and without BV, and three of
four of the women with BV did not report malodor-
ous discharge at all, even when asked specifically.
Thus, asymptomatic BV was more common among
these pregnant women than symptomatic BV. Ac-
cordingly, the ability to predict which women have
BV by careful questioning about specific symptoms
does not seem to be possible.
None of the women in our study spontaneously
complained about discharge, and only a very few
felt worried by the character of the discharge when
questioned. Surprisingly, about 25;% of all the
women without BV felt they had a foul-smelling
discharge when asked specifically. One explana-
tion might be that body secretions are a subject
fraught with taboo and guilt, and that many women
consider any smell from the vagina as a foul-
smelling odor.
McGregor et al.9 failed to reduce the overall in-
cidence of adverse pregnancy outcome by treating
only women with symptomatic BV. When all
women were screened and women with BV were
treated, the incidence of preterm delivery was re-
duced. This is supported by our findings, which
indicate that screening for BV only among symp-
tomatic women is insufficient when trying to pre-
dict women at increased risk of having BV.
Only a few studies deal with the spontaneous
course of untreated BV during pregnancy, lz, 13 In
our study, more than one third of the women with
BV at 30 gestational weeks did not fulfill the cri-
teria for BV three weeks later. None of the women
without BV had BV at the follow-up visit.
The relative risk of preterm delivery for women
with BV compared with women without BV has
been reported to be between 1.4 and 6.9. 3, 18 We
found that women with BV more often had a pre-
term delivery than women without BV, although
the association was not significant (odds ratio was
1.8 [confidence interval was 0.4-9.0]). Recent stud-
ies indicate that the strongest association between
BV and preterm delivery is seen when BV is diag-
nosed in early pregnancy. 7, 13 In our study women
were included in early third trimester and for this
reason our risk estimate may be underestimated.
However, the small number ofwomen in our study
complicates the interpretation.
We observed a higher frequency of smokers
among women with BV than among women with-
out BV. This has also been noted by others. 13’ 19, 20
In studies of abnormal vaginal flora and preterm
delivery, smoking has usually been considered a
potential confounder. However, whether the asso-
ciation between smoking and BV is causal or sta-
tistical is still controversial, and smoking might be
an intermediate factor in the cause-effect relation.
Thus, controlling for smoking when calculating the
relative risk of preterm delivery among women
with BV would result in a lowering of the risk es-
timates.
In summary, we showed that asymptomatic BV
in pregnancy is common, and not even by asking
women specifically about the character of their dis-
charge could we identify women with BV. Women
with BV are more often smokers than women with-
out BV.
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